Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil* Doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma

Giorgio Cocconi, P. Carlini, A. Gamboni, S. Gasperoni, C. Rodinò, S. Zironi, G. Bisagni, S. Porrozzi, F. Cognetti, F. Di Costanzo, R. Canaletti, E. M. Ruggeri, R. Camisa, F. Pucci

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil* Doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences